Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes

Hepatology

Volumn 28, Issue 6, 1998, Pages 1674-1679

  Frangeul, Lionel ^a   Cresta, Pascale ^b   Perrin, Michele ^a   Lunel, Françoise ^b   Opolon, Pierre ^a   Agut, Henri ^a   Huraux, Jean Marie ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; CODON; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS MUTATION;

EID: 0031793049     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280630     Document Type: Article

References (23)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
2. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. HEPATOLOGY 1995;22:1050-1056.
3. Diodati G, Bonetti P, Tagger A, Casarin C, Noventa F, Ribero M, Fasola M, et al. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C; evaluation of HCV genotypes during and after long-term follow-up. Dig Dis Sci 1994;39:2497-2502.
4. Frangeul L, Cresta P, Perrin M, Duverlie G, Khorsi H, Musset L, Opolon P, et al. Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon. J Hepatol 1998;28:538-543.
5. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, et al. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. HEPATOLOGY 1997;25:750-753.
6. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b - sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995;96:224-230.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
8. Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. HEPATOLOGY 1997;25:740-744.
9. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 1997;27:72-77.
10. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 1997;113:567-572.
11. Hofgartner WT, Polyak SJ, Sullivan DG, Carithers RL, Gretch DR. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype la or Ib. J Med Virol 1997;53:118-126.
12. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A non-B hepatitis. Proc Natl Acad Sci U S A 1990;87:9524-9628.
13. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
14. Sakamoto M, Akahane Y, Tsuda F, Tanaka T, Woodfield DG, Okamoto H. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol 1994;75:1761-1768.
15. Nakao H, Okamoto H, Tokida H, Inoue T, Iizuka H, Pozzato G, Mishiro S. Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers. Arch Virol 1996;141:701-704.
16. Cheung RC, Matsui SM, Greenberg HB. Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles. J Clin Microbiol 1994;32:2593-2597.
17. Le Van Kim C, Mouvo I, Brossard Y, Chavigné J, Cartrou J, Collin Y. PCR based determination of Rhc and RhE status of foetuses at risk of rhc and rhE haemolytic disease. Br J Haematol 1994;88:193-195.
18. Okamoto H, Okada S, Sugiyama Y, Kurai K, Lizuka H, Machida A. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991;72:2697-2704.
19. Okamoto H, Kurai K, Okada SC, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992;188:331-341.
20. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N. Interferon sensitivity determining sequence of the hepatitis C virus genome. [Abstract] HEPATOLOGY 1996;24:460.
21. Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997;230:217-227.
22. Kato N, Lan KH, OnoNita SK, Shiratori Y, Omata M. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997;71:8856-8859.
23. Peitsch MC. Protein modeling by e-mail. Bio-Technology 1995;13:658-660.